Copyright: ©Author(s) 2026.
World J Hepatol. Mar 27, 2026; 18(3): 112850
Published online Mar 27, 2026. doi: 10.4254/wjh.v18.i3.112850
Published online Mar 27, 2026. doi: 10.4254/wjh.v18.i3.112850
Figure 3 Heatmaps representing Pearson correlation coefficients among insulin-like growth factor 2, intestinal fatty-acid-binding protein, and interferon-gamma (all measured in ng/L) in the hepatitis C virus-coronavirus disease 2019 coinfected group, coronavirus disease 2019 group, and hepatitis C virus group.
Each cell shows the strength and direction of the correlation between pairs of biomarkers, with color intensity indicating correlation magnitude (blue: Negative, red: Positive). While most correlations were weak and not statistically significant, a borderline significant positive correlation was observed between intestinal fatty-acid-binding protein and interferon-γ in the coronavirus disease-2019 group (r = 0.261, P = 0.050). HCV: Hepatitis C virus; COVID-19: Coronavirus disease 2019; IFN: Interferon; IGF: Insulin-like growth factor; I-FABP: Intestinal fatty-acid-binding protein.
- Citation: Mohamed AA, Abdel-Hamid RM, Amin A, A Gawad EAH, Saed SM, Gaber DA, Ezz Al Arab M, El-Agawy W, AbuRahma MZA, Elosaily HH, Shaaban EE, Ismail SA, Sakr AA. Immunogenetic and molecular biomarkers in COVID-19 and hepatitis C virus infection: Evaluating the diagnostic potential of HLA (rs1131500), IGF-2, and I-FABP. World J Hepatol 2026; 18(3): 112850
- URL: https://www.wjgnet.com/1948-5182/full/v18/i3/112850.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i3.112850